11 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/11/2978268/0/en/Based-on-Recent-FDA-Feedback-RAPT-Therapeutics-Stops-Zelnecirnon-Program-Following-Clinical-Hold-Due-to-Single-SAE-of-Severe-Liver-Injury.html
LOOKING FOR A SUPPLIER?